Seguimiento de transacciones de insiders en los distintos mercados.
| 30 días | 90 días | 120 días | |
|---|---|---|---|
| Rentabilidad media | -10% | 8.2% | 15.1% |
| Tasa de éxito | 0% | 68% | 82% |
| Transacciones |
7
100% Comprar
|
34
71% Comprar
|
47
69% Comprar
|
| Posición | Compañía | Período |
|---|---|---|
| Chief Medical Officer | electroCore, Inc. | 8 de marzo de 2019 - |
| Director | Immune Pharmaceuticals Inc | 6 de marzo de 2019 - |
| President, Interim Chief Executive Officer, Chief Operating Officer, Chief Medical Officer, Director | Immune Pharmaceuticals Inc | 28 de agosto de 2018 - 6 de marzo de 2019 |
| Chief Operating Officer, Chief Medical Officer | Immune Pharmaceuticals Inc | 14 de agosto de 2017 - 28 de agosto de 2018 |
| Independent Director | Navidea Biopharmaceuticals Inc | 23 de marzo de 2016 - 9 de octubre de 2017 |
| Chief Executive Officer | Brainstorm Cell Therapeutics Inc | 9 de junio de 2014 - 22 de septiembre de 2015 |
Buscar